Radiofrequency hyperthermia therapy of murine melanoma: A comparison of fractionated versus single-dose treatments

S. A. Don, Scott E Klewer, N. Levine

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The effects of single and fractionated doses of radiofrequency hyperthermia were investigated in the treatment of cutaneous murine melanoma. S91 murine melanoma cells were implanted into preformed intradermal blister cavities on the backs of DBA/2J mice. Evaluation of treatment response was undertaken after single and fractionated doses of hyperthermia. A single 60-second treatment at 46°C did not result in any complete regressions, while 3 weekly 46°C treatments produced a 40% incidence of tumor regression. Higher temperature therapy was associated with improved cure rates. A single treatment for 60 seconds at 50°C resulted in a 25% complete response rate while 3 weekly 50°C treatments resulted in the eradication of 92% of the treated tumors. In those tumors that responded only partially to hyperthermia, fractionated low- (46°C) and (50°C) high-dose regimens resulted in significantly smaller melanomas than single-treatment schedules at the same temperatures. It is concluded that fractionated hyperthermia is an effective modality in the control of intracutaneous murine melanoma. If other cutaneous malignancies are also sensitive to heat, this may provide a useful nonsurgical means of treating skin cancer.

Original languageEnglish (US)
Pages (from-to)845-849
Number of pages5
JournalJournal of Dermatologic Surgery and Oncology
Volume15
Issue number8
StatePublished - 1989

Fingerprint

Melanoma
Fever
Neoplasms
Inbred DBA Mouse
Skin
Temperature
Skin Neoplasms
Therapeutics
Blister
Appointments and Schedules
Hot Temperature
Incidence

ASJC Scopus subject areas

  • Dermatology
  • Oncology

Cite this

@article{98e79934538943438f0b4b43dc557693,
title = "Radiofrequency hyperthermia therapy of murine melanoma: A comparison of fractionated versus single-dose treatments",
abstract = "The effects of single and fractionated doses of radiofrequency hyperthermia were investigated in the treatment of cutaneous murine melanoma. S91 murine melanoma cells were implanted into preformed intradermal blister cavities on the backs of DBA/2J mice. Evaluation of treatment response was undertaken after single and fractionated doses of hyperthermia. A single 60-second treatment at 46°C did not result in any complete regressions, while 3 weekly 46°C treatments produced a 40{\%} incidence of tumor regression. Higher temperature therapy was associated with improved cure rates. A single treatment for 60 seconds at 50°C resulted in a 25{\%} complete response rate while 3 weekly 50°C treatments resulted in the eradication of 92{\%} of the treated tumors. In those tumors that responded only partially to hyperthermia, fractionated low- (46°C) and (50°C) high-dose regimens resulted in significantly smaller melanomas than single-treatment schedules at the same temperatures. It is concluded that fractionated hyperthermia is an effective modality in the control of intracutaneous murine melanoma. If other cutaneous malignancies are also sensitive to heat, this may provide a useful nonsurgical means of treating skin cancer.",
author = "Don, {S. A.} and Klewer, {Scott E} and N. Levine",
year = "1989",
language = "English (US)",
volume = "15",
pages = "845--849",
journal = "Dermatologic Surgery",
issn = "1076-0512",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Radiofrequency hyperthermia therapy of murine melanoma

T2 - A comparison of fractionated versus single-dose treatments

AU - Don, S. A.

AU - Klewer, Scott E

AU - Levine, N.

PY - 1989

Y1 - 1989

N2 - The effects of single and fractionated doses of radiofrequency hyperthermia were investigated in the treatment of cutaneous murine melanoma. S91 murine melanoma cells were implanted into preformed intradermal blister cavities on the backs of DBA/2J mice. Evaluation of treatment response was undertaken after single and fractionated doses of hyperthermia. A single 60-second treatment at 46°C did not result in any complete regressions, while 3 weekly 46°C treatments produced a 40% incidence of tumor regression. Higher temperature therapy was associated with improved cure rates. A single treatment for 60 seconds at 50°C resulted in a 25% complete response rate while 3 weekly 50°C treatments resulted in the eradication of 92% of the treated tumors. In those tumors that responded only partially to hyperthermia, fractionated low- (46°C) and (50°C) high-dose regimens resulted in significantly smaller melanomas than single-treatment schedules at the same temperatures. It is concluded that fractionated hyperthermia is an effective modality in the control of intracutaneous murine melanoma. If other cutaneous malignancies are also sensitive to heat, this may provide a useful nonsurgical means of treating skin cancer.

AB - The effects of single and fractionated doses of radiofrequency hyperthermia were investigated in the treatment of cutaneous murine melanoma. S91 murine melanoma cells were implanted into preformed intradermal blister cavities on the backs of DBA/2J mice. Evaluation of treatment response was undertaken after single and fractionated doses of hyperthermia. A single 60-second treatment at 46°C did not result in any complete regressions, while 3 weekly 46°C treatments produced a 40% incidence of tumor regression. Higher temperature therapy was associated with improved cure rates. A single treatment for 60 seconds at 50°C resulted in a 25% complete response rate while 3 weekly 50°C treatments resulted in the eradication of 92% of the treated tumors. In those tumors that responded only partially to hyperthermia, fractionated low- (46°C) and (50°C) high-dose regimens resulted in significantly smaller melanomas than single-treatment schedules at the same temperatures. It is concluded that fractionated hyperthermia is an effective modality in the control of intracutaneous murine melanoma. If other cutaneous malignancies are also sensitive to heat, this may provide a useful nonsurgical means of treating skin cancer.

UR - http://www.scopus.com/inward/record.url?scp=0024347322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024347322&partnerID=8YFLogxK

M3 - Article

C2 - 2754088

AN - SCOPUS:0024347322

VL - 15

SP - 845

EP - 849

JO - Dermatologic Surgery

JF - Dermatologic Surgery

SN - 1076-0512

IS - 8

ER -